Serial Number | 75412158 |
Word Mark | M |
Filing Date | Tuesday, December 30, 1997 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Saturday, April 5, 2003 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3S07 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, January 11, 2000 |
Description of Mark | The mark consists of stylized "M". |
Goods and Services | chemical and genetic engineering of therapeutic molecules; pharmaceutical research and development services rendered to others; research services for discovering antibodies, antisense drugs, peptides, proteins, and gene therapy drugs; computer services, namely, providing access to databases of life sciences information via global, national, and local computer networks; computer services, namely, creating and customizing databases for others in the field of life sciences; computer services, namely, custom software design for others; computer services, namely, software support and maintenance; computer services, namely, computational chemistry, biology and genetics services for others; medical and diagnostic services, namely, diagnosing preventing, and predicting diseases, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing disease treatments based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring an computer tracking of a patient's health progress; research services, namely, identification and characterization of peptides and proteins for use in developing diagnostic and therapeutic products and services; research services, namely, identifying genes; drug screening using cultured microorganisms |
Pseudo Mark | M |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, February 20, 1998 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Millennium Pharmaceuticals, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02139 |
Party Name | Millennium Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02139 |
Event Date | Event Description |
Wednesday, September 17, 2003 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, November 5, 2002 | EXTENSION 5 GRANTED |
Thursday, October 3, 2002 | EXTENSION 5 FILED |
Wednesday, September 25, 2002 | EXTENSION 4 GRANTED |
Thursday, April 4, 2002 | EXTENSION 4 FILED |
Thursday, October 3, 2002 | TEAS EXTENSION RECEIVED |
Wednesday, September 25, 2002 | PETITION TO REVIVE-GRANTED |
Friday, April 12, 2002 | PETITION TO REVIVE-RECEIVED |
Monday, August 12, 2002 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, October 16, 2001 | EXTENSION 3 GRANTED |
Thursday, October 4, 2001 | EXTENSION 3 FILED |
Friday, May 4, 2001 | EXTENSION 2 GRANTED |
Wednesday, April 4, 2001 | EXTENSION 2 FILED |
Tuesday, December 12, 2000 | EXTENSION 1 GRANTED |
Wednesday, September 27, 2000 | EXTENSION 1 FILED |
Tuesday, April 4, 2000 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, January 11, 2000 | PUBLISHED FOR OPPOSITION |
Friday, December 10, 1999 | NOTICE OF PUBLICATION |
Thursday, October 21, 1999 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, September 16, 1999 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, June 17, 1999 | FINAL REFUSAL MAILED |
Friday, March 26, 1999 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, September 24, 1998 | NON-FINAL ACTION MAILED |
Monday, September 21, 1998 | ASSIGNED TO EXAMINER |
Wednesday, September 2, 1998 | ASSIGNED TO EXAMINER |